Literature DB >> 24627157

AFP-producing urothelial carcinoma of the bladder: a case report.

Jianan Ye1, Xianlin Xu, Min Fan, Dong Xue, Qianfeng Zhuang.   

Abstract

We report a case of urothelial carcinoma of the urinary bladder with concurrent alpha-fetoprotein (AFP) elevation. A 60-year-old male was admitted for gross hematuria. Subsequent analyses revealed elevated serum AFP levels (970.20 ng/ml). He had no history of hepatitis, and hepatobiliary disease was not detected on computed tomography or ultrasound. Carcino-embryonic antigen was normal. The patient underwent radical cystectomy and was found to have a high-grade urothelial carcinoma of bladder on pathology. In addition, immunohistochemical staining of the tumor cells showed strong AFP positivity. Postoperatively, serum AFP levels decreased gradually to normal. In summary, urothelial carcinoma of the urinary bladder with AFP elevation is rare, and the mechanism and prognosis require further exploration.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24627157     DOI: 10.1007/s11255-014-0691-4

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  10 in total

1.  Case of alpha-fetoprotein-producing transitional cell carcinoma of the renal pelvis.

Authors:  Yoshiyuki Shiga; Koji Kawai; Toru Shimazui; Tatsuo Iijima; Masayuki Noguchi; Hideyuki Akaza
Journal:  Int J Urol       Date:  2004-02       Impact factor: 3.369

2.  α-Fetoprotein-Producing Non-Germ Cell Tumors of the Urological System.

Authors:  Mona El-Bahrawy
Journal:  Rev Urol       Date:  2011

3.  Hepatoid adenocarcinoma of the renal pelvis producing alpha-fetoprotein of hepatic type and bile pigment.

Authors:  H Ishikura; T Ishiguro; C Enatsu; H Fujii; Y Kakuta; M Kanda; T Yoshiki
Journal:  Cancer       Date:  1991-06-15       Impact factor: 6.860

4.  The effect of squamous and/or glandular differentiation on recurrence, progression and survival in urothelial carcinoma of bladder.

Authors:  Fikret Erdemir; Murat Tunc; Faruk Ozcan; Bekir S Parlaktas; Nihat Uluocak; Isin Kilicaslan; Ozgur Gokce
Journal:  Int Urol Nephrol       Date:  2007-03-02       Impact factor: 2.370

5.  A unique case of an alpha-fetoprotein-producing lung cancer with testicular metastasis.

Authors:  Jennifer M Willder; Andrew M Thomson; Kenneth M Grigor; Grahame Howard; Grant D Stewart
Journal:  Can Urol Assoc J       Date:  2012-10       Impact factor: 1.862

Review 6.  Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis.

Authors:  Samir Gupta; Stephen Bent; Jeffrey Kohlwes
Journal:  Ann Intern Med       Date:  2003-07-01       Impact factor: 25.391

7.  Alpha-fetoprotein-producing transitional cell carcinoma of the urinary bladder: a case report.

Authors:  Chang-Hsien Lu; Wen-Chi Chou; Yu-Shin Hung; Kun-Yun Yeh; Swei Sheu; Chuang-Chi Liaw
Journal:  Int Urol Nephrol       Date:  2008-09-03       Impact factor: 2.370

8.  Concurrent cisplatin, 5-fluorouracil, leucovorin, and radiotherapy for invasive bladder cancer.

Authors:  Wen-Cheng Chen; Chuag-Chi Liaw; Cheng-Keng Chuang; Miao-Fen Chen; Chih-Shou Chen; Paul Yann Lin; Phei-Lang Chang; Sheng-Hsien Chu; Chun-Te Wu; Ji-Hong Hong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-07-01       Impact factor: 7.038

9.  Alpha-fetoprotein producing undifferentiated carcinoma of the bladder.

Authors:  K Yamada; Y Fujioka; Y Ebihara; I Kiriyama; H Suzuki; M Akimoto
Journal:  J Urol       Date:  1994-09       Impact factor: 7.450

10.  TPA, TATI, CEA, AFP, beta-HCG, PSA, SCC, and CA 19-9 for monitoring transitional cell carcinoma of the bladder.

Authors:  D Pectasides; D Bafaloucos; F Antoniou; L Gogou; N Economides; J Varthalitis; M Dimitriades; P Kosmidis; A Athanassiou
Journal:  Am J Clin Oncol       Date:  1996-06       Impact factor: 2.339

  10 in total
  1 in total

1.  Evaluation of plasma D-dimer for the diagnosis in Chinese patients with hepatocellular carcinoma: A meta-analysis.

Authors:  Ping Fang; Lijun Du; Decheng Cai
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.